Catalyst Wire Dossier Catalyst Wire Dossier

Tenofovir Amibufenamide

tenofovir amibufenamide · Jiangsu Hansoh Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Tenofovir Amibufenamide, covering 2024-12-19 to 2025-12-22. Get the full timeline:

Most recent: Clinical Trial Update: Drug-Drug Interaction Study Between Hydronidone and Entecavir, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide, and Tenofovir Amibufenamide [Phase 1]

See pricing